Literature DB >> 25804404

Partial USH2A deletions contribute to Usher syndrome in Denmark.

Shzeena Dad1, Nanna D Rendtorff2,3, Erik Kann1, Anders Albrechtsen4, Mana M Mehrjouy2, Mads Bak2, Niels Tommerup2, Lisbeth Tranebjærg2,3, Thomas Rosenberg5, Hanne Jensen5, Lisbeth B Møller1.   

Abstract

Usher syndrome is an autosomal recessive disorder characterized by congenital hearing impairment, progressive visual loss owing to retinitis pigmentosa and in some cases vestibular dysfunction. Usher syndrome is divided into three subtypes, USH1, USH2 and USH3. Twelve loci and eleven genes have so far been identified. Duplications and deletions in PCDH15 and USH2A that lead to USH1 and USH2, respectively, have previously been identified in patients from United Kingdom, Spain and Italy. In this study, we investigate the proportion of exon deletions and duplications in PCDH15 and USH2A in 20 USH1 and 30 USH2 patients from Denmark using multiplex ligation-dependent probe amplification (MLPA). Two heterozygous deletions were identified in USH2A, but no deletions or duplications were identified in PCDH15. Next-generation mate-pair sequencing was used to identify the exact breakpoints of the two deletions identified in USH2A. Our results suggest that USH2 is caused by USH2A exon deletions in a small fraction of the patients, whereas deletions or duplications in PCDH15 might be rare in Danish Usher patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25804404      PMCID: PMC4795208          DOI: 10.1038/ejhg.2015.54

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  33 in total

1.  Identification of novel USH2A mutations: implications for the structure of USH2A protein.

Authors:  B Dreyer; L Tranebjaerg; T Rosenberg; M D Weston; W J Kimberling; O Nilssen
Journal:  Eur J Hum Genet       Date:  2000-07       Impact factor: 4.246

Review 2.  Update on Usher syndrome.

Authors:  Zubin Saihan; Andrew R Webster; Linda Luxon; Maria Bitner-Glindzicz
Journal:  Curr Opin Neurol       Date:  2009-02       Impact factor: 5.710

3.  Large genomic rearrangements within the PCDH15 gene are a significant cause of USH1F syndrome.

Authors:  Sandie Le Guédard; Valérie Faugère; Sue Malcolm; Mireille Claustres; Anne-Françoise Roux
Journal:  Mol Vis       Date:  2007-01-26       Impact factor: 2.367

4.  Usher syndrome: definition and estimate of prevalence from two high-risk populations.

Authors:  J A Boughman; M Vernon; K A Shaver
Journal:  J Chronic Dis       Date:  1983

5.  Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%.

Authors:  A-F Roux; V Faugère; S Le Guédard; N Pallares-Ruiz; A Vielle; S Chambert; S Marlin; C Hamel; B Gilbert; S Malcolm; M Claustres
Journal:  J Med Genet       Date:  2006-05-05       Impact factor: 6.318

6.  Homozygosity for a gross partial gene deletion of the C-terminal end of ATP7B in a Wilson patient with hepatic and no neurological manifestations.

Authors:  Lisbeth Birk Møller; Peter Ott; Connie Lund; Nina Horn
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

7.  Prevalence and geographical distribution of Usher syndrome in Germany.

Authors:  Ulrich H M Spandau; Klaus Rohrschneider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-05-23       Impact factor: 3.117

8.  Microarray-based mutation analysis of 183 Spanish families with Usher syndrome.

Authors:  Teresa Jaijo; Elena Aller; Gema García-García; María J Aparisi; Sara Bernal; Almudena Avila-Fernández; Isabel Barragán; Montserrat Baiget; Carmen Ayuso; Guillermo Antiñolo; Manuel Díaz-Llopis; Maigi Külm; Magdalena Beneyto; Carmen Nájera; Jose M Millán
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-13       Impact factor: 4.799

9.  Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study.

Authors:  Polona Le Quesne Stabej; Zubin Saihan; Nell Rangesh; Heather B Steele-Stallard; John Ambrose; Alison Coffey; Jenny Emmerson; Elene Haralambous; Yasmin Hughes; Karen P Steel; Linda M Luxon; Andrew R Webster; Maria Bitner-Glindzicz
Journal:  J Med Genet       Date:  2011-12-01       Impact factor: 6.318

10.  Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.

Authors:  Hidekane Yoshimura; Satoshi Iwasaki; Shin-Ya Nishio; Kozo Kumakawa; Tetsuya Tono; Yumiko Kobayashi; Hiroaki Sato; Kyoko Nagai; Kotaro Ishikawa; Tetsuo Ikezono; Yasushi Naito; Kunihiro Fukushima; Chie Oshikawa; Takashi Kimitsuki; Hiroshi Nakanishi; Shin-Ichi Usami
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

View more
  3 in total

1.  The role of CNVs in the etiology of rare autosomal recessive disorders: the example of TRAPPC9-associated intellectual disability.

Authors:  Jérémie Mortreux; Tiffany Busa; Dominique P Germain; Gwenaël Nadeau; Jacques Puechberty; Christine Coubes; Vincent Gatinois; Pierre Cacciagli; Yannis Duffourd; Jean-Marc Pinard; Hélène Tevissen; Laurent Villard; Damien Sanlaville; Nicole Philip; Chantal Missirian
Journal:  Eur J Hum Genet       Date:  2017-11-29       Impact factor: 4.246

2.  Molecular Inversion Probe-Based Sequencing of USH2A Exons and Splice Sites as a Cost-Effective Screening Tool in USH2 and arRP Cases.

Authors:  Janine Reurink; Adrian Dockery; Dominika Oziębło; G Jane Farrar; Monika Ołdak; Jacoline B Ten Brink; Arthur A Bergen; Tuula Rinne; Helger G Yntema; Ronald J E Pennings; L Ingeborgh van den Born; Marco Aben; Jaap Oostrik; Hanka Venselaar; Astrid S Plomp; M Imran Khan; Erwin van Wijk; Frans P M Cremers; Susanne Roosing; Hannie Kremer
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

3.  Usher syndrome in Denmark: mutation spectrum and some clinical observations.

Authors:  Shzeena Dad; Nanna Dahl Rendtorff; Lisbeth Tranebjærg; Karen Grønskov; Helena Gásdal Karstensen; Vigdis Brox; Øivind Nilssen; Anne-Françoise Roux; Thomas Rosenberg; Hanne Jensen; Lisbeth Birk Møller
Journal:  Mol Genet Genomic Med       Date:  2016-06-28       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.